Evaluation of Complete Blood Count–Derived Inflammatory Markers as Predictors of Poor Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Retrospective Study
DOI:
https://doi.org/10.54361/LJMR.20.2.85Keywords:
Type 2 diabetes mellitus, HbA1c, complete blood count, inflammation, neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, glycemic controlAbstract
Background: Type 2 diabetes mellitus (T2DM) is accompanied by metabolic dysregulation and chronic low-grade inflammation. Routine complete blood count (CBC) parameters and derived inflammatory ratios may provide accessible complementary indicators of this inflammatory state. Methods: This retrospective study included 161 patients with T2DM attending the diabetes clinic at Al-Zahra General Hospital. Patients were classified as controlled (HbA1c <7%; n=69) or uncontrolled (HbA1c ≥7%; n=92). CBC and HbA1c obtained during the same visit were analyzed. NLR and MLR were calculated. Mann–Whitney U, two-way ANOVA, correlation, linear regression, logistic regression, and ROC analyses were performed. Results: WBC, neutrophils, lymphocytes, monocytes, NLR, and MLR were significantly higher in the uncontrolled group (all p<0.001). HbA1c correlated strongly with WBC (r=0.776) and neutrophils (r=0.769). Linear regression explained 66.1% of HbA1c variance, with WBC as the strongest independent predictor (β=1.463, p<0.001). Logistic regression identified WBC (OR=24.41; 95% CI 5.53–107.65) and NLR (OR=7.41; 95% CI 2.14–25.62) as independent predictors. AUCs were 0.884 for neutrophils, 0.873 for WBC, and 0.768 for NLR. Conclusion: Poor glycemic control was consistently associated with higher CBC-derived inflammatory markers. WBC, neutrophils, and NLR may provide useful complementary information, although prospective external validation is required.
Downloads
References
1. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98-107.
2. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111-1119.
3. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793-1801.
4. Nagareddy PR, Murphy AJ, Stirzaker RA, Hu Y, Yu S, Miller RG, et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab. 2013;17(5):695-708.
5. Demirtas L, Degirmenci H, Akbas EM, Ozcicek A, Timuroglu A, Gurel A, et al. Association of hematological indices with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med. 2015;8(7):11420-11427.
6. Sefil F, Ulutas KT, Dokuyucu R, et al. Investigation of neutrophil-lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J Int Med Res. 2014;42(2):581-588.
7. Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602-1606.
8. Elimam H, Abdulla AM, Taha IM. Inflammatory markers and control of type 2 diabetes mellitus. Diabetes Metab Syndr. 2019;13(1):800-804.
9. Mertoglu C, Gunay M. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr. 2017;11 Suppl 1:S127-S131.
10. Chen H, Wu C, Cao L, Wang R, Zhang TY, He Z. The association between the neutrophil-to-lymphocyte ratio and type 2 diabetes mellitus: a cross-sectional study. BMC Endocr Disord. 2024;24(1):107.
11. Dayama N, Yadav SK, Saxena P, Kashnia R, Sharda K. A study of relationships between the HbA1c level and inflammatory markers, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in controlled and uncontrolled type 2 diabetes mellitus. J Assoc Physicians India. 2024;72(3):24-26.
12. Suguna S, Kusumadevi MS. Correlation of HbA1c levels with monocyte-lymphocyte and platelet-lymphocyte ratios in type 2 diabetics of Bengaluru city. Int J Physiol. 2019;7(4):99-103.
13. Taban N, Bhat MH, Sayeed SI, Majid S, Lone SS, Muzaffar M, et al. Comparative evaluation of inflammatory markers NLR, PLR, IL-6, and HbA1c in type 2 diabetes mellitus: a hospital based study. Med J Islam Repub Iran. 2025;39:48.
14. Zhang Y, Liu H. Correlation between insulin resistance and the rate of neutrophils-lymphocytes, monocytes-lymphocytes, platelets-lymphocytes in type 2 diabetic patients. BMC Endocr Disord. 2024;24:42.
1. Editorial note: The reference list should be cross-checked against the original bibliography and the target journal's requirements before submission.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Libyan Journal of Medical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
https://portal.issn.org/resource/ISSN/2413-6069
